Compile Data Set for Download or QSAR
Report error Found 10 Enz. Inhib. hit(s) with all data for entry = 9493
TargetEpidermal growth factor receptor(Human)
The State University of New Jersey

US Patent
LigandPNGBDBM470595(US10815244, Example DD)
Affinity DataIC50: 100nMAssay Description:Briefly, the assay method measures ADP formed from EGFR kinase activity using luminescence derived from ATP-Luciferase detection system. Purified EGF...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2021
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
The State University of New Jersey

US Patent
LigandPNGBDBM470592(US10815244, Example AA)
Affinity DataIC50: 100nMAssay Description:Briefly, the assay method measures ADP formed from EGFR kinase activity using luminescence derived from ATP-Luciferase detection system. Purified EGF...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2021
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
The State University of New Jersey

US Patent
LigandPNGBDBM470591(US10815244, Example Z)
Affinity DataIC50: 100nMAssay Description:Briefly, the assay method measures ADP formed from EGFR kinase activity using luminescence derived from ATP-Luciferase detection system. Purified EGF...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2021
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
The State University of New Jersey

US Patent
LigandPNGBDBM470588(US10815244, Example U)
Affinity DataIC50: 100nMAssay Description:Briefly, the assay method measures ADP formed from EGFR kinase activity using luminescence derived from ATP-Luciferase detection system. Purified EGF...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2021
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
The State University of New Jersey

US Patent
LigandPNGBDBM470587(US10815244, Example T)
Affinity DataIC50: 100nMAssay Description:Briefly, the assay method measures ADP formed from EGFR kinase activity using luminescence derived from ATP-Luciferase detection system. Purified EGF...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2021
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
The State University of New Jersey

US Patent
LigandPNGBDBM470596(US10815244, Example EE)
Affinity DataIC50: 500nMAssay Description:Briefly, the assay method measures ADP formed from EGFR kinase activity using luminescence derived from ATP-Luciferase detection system. Purified EGF...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2021
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
The State University of New Jersey

US Patent
LigandPNGBDBM470594(US10815244, Example CC)
Affinity DataIC50: 500nMAssay Description:Briefly, the assay method measures ADP formed from EGFR kinase activity using luminescence derived from ATP-Luciferase detection system. Purified EGF...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2021
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
The State University of New Jersey

US Patent
LigandPNGBDBM470593(US10815244, Example BB)
Affinity DataIC50: 500nMAssay Description:Briefly, the assay method measures ADP formed from EGFR kinase activity using luminescence derived from ATP-Luciferase detection system. Purified EGF...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2021
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
The State University of New Jersey

US Patent
LigandPNGBDBM470589(US10815244, Example X)
Affinity DataIC50: 500nMAssay Description:Briefly, the assay method measures ADP formed from EGFR kinase activity using luminescence derived from ATP-Luciferase detection system. Purified EGF...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2021
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
The State University of New Jersey

US Patent
LigandPNGBDBM470590(US10815244, Example Y)
Affinity DataIC50: 1.00E+3nMAssay Description:Briefly, the assay method measures ADP formed from EGFR kinase activity using luminescence derived from ATP-Luciferase detection system. Purified EGF...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2021
Entry Details
US Patent